Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer.

Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer. — المؤلف: Kusumoto, Tetsuya — ESMO open 2018

المؤلف
Kusumoto, Tetsuya
النشر
ESMO open 2018
الوصف
e000428 p.